Customer Concentration (Tables)

12 Months Ended

Dec. 31, 2016

Risks and Uncertainties [Abstract]

Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]

	Year Ended December 31,
	2016		2015		2014
Income Generating Assets:
Genentech	43	%	70	%	71	%
Biogen	24	%	9	%	10	%
Depomed	13	%	9	%	7	%

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

The following tables presents total receivables from licensee and other, which individually account for 10% or more of the Company’s total receivables from licensee and other asset balance:

	December 31,
(In thousands)	2016		2015
Depomed	$	6,000	$	—
Cardinal Health	7,663		—
McKesson	9,135		—
AmerisourceBergen	8,039		—
Other	9,283		—
Total receivables from licensee and other	$	40,120	$	—

	Year Ended December 31,
(In thousands)	2016		2015		2014
United States	$	157,327	$	339,596	$	334,325
Europe	82,534		250,852		246,825
Other	4,440		—		75
Total revenues	$	244,301	$	590,448	$	581,225

Long-lived Assets by Geographic Areas [Table Text Block]

The following table presents total long-lived assets by location:

	December 31,
(In thousands)	2016		2015
United States	$	13	$	31
Ireland	25		—
Total long-lived assets(1)	$	38	$	31

_____________________

⁽¹⁾ Long-lived assets consist of property and equipment.